|
Featured News Confusing Labeling Found on Many Nonprescription Kids' Meds
November 2010 The admonishment to parents to carefully follow the directions on the labels of over-the-counter kids' medicines may be futile, new research suggests. Read more...
New Drug Approvals
The following drugs have recently been approved by the FDA.
New Indications and Dosage Forms
Drugs that have gained FDA approval for the treatment of additional diseases/conditions or new dosage forms/regimens.
First-Time Generic Approvals
First Time Generics are those drug products that have never been approved before as generic drug products and are new generic products to the marketplace.
FDA Drug Safety Labeling Changes
This is a summary of the FDA drug labeling changes for October 2010. Click on a drug name to view the changes in more detail.
| Key to Label Sections: |
| BW - Boxed Warning |
C - Contraindications |
| W - Warnings |
P - Precautions |
| AR - Adverse Reactions |
PPI - Patient Package Insert |
| MG - Medication Guide |
PCI - Patient Counseling Information |
| |
Sections Modified |
| Drug Name |
BW |
C |
W |
P |
AR |
PPI |
MG |
PCI |
Altace (ramipril) capsules |
x |
- |
x |
x |
- |
- |
- |
- |
Letairis (ambrisentan) tablets |
x |
x |
x |
x |
x |
- |
- |
- |
Invirase (saquinavir mesylate) tablets |
- |
x |
x |
x |
- |
- |
- |
- |
Aldara (imiquimod) cream |
- |
- |
x |
x |
- |
- |
- |
- |
Depo-Provera Contraceptive injection (medroxyprogesterone acetate) injectable suspension |
- |
- |
x |
x |
- |
- |
- |
- |
Enablex (darifenacin) extended-release tablets |
- |
- |
x |
x |
x |
x |
- |
- |
Fragmin (dalteparin sodium) injection |
- |
- |
x |
x |
- |
- |
- |
- |
Gris-PEG (griseofulvin ultramicrosized) tablets |
- |
- |
x |
- |
x |
- |
- |
- |
Motrin Junior Strength chewable tablets, 100 mg
|
- |
- |
x |
- |
- |
- |
- |
- |
Lamictal (lamotrigine) tablets, chewable dispersible tablets, Lamictal ODT (lamotrigine) orally disintegrating tablets, and Lamictal XR (lamotrigine) extended-release tablets |
- |
- |
x |
x |
- |
- |
- |
- |
Lasix (furosemide) tablets |
- |
- |
x |
x |
x |
- |
- |
- |
Myfortic (mycophenolic acid) delayed-release tablet |
- |
- |
x |
x |
- |
- |
- |
- |
Nexavar (sorafenib tosylate) tablets |
- |
- |
x |
x |
x |
- |
- |
- |
Nuvigil (armodafinil) tablets |
- |
- |
x |
- |
- |
- |
- |
- |
Precedex (dexmedetomidine hydrochloride) injection |
- |
- |
x |
x |
x |
- |
- |
- |
Procardia XL (nifedipine) extended release tablets |
- |
- |
x |
x |
x |
- |
- |
- |
Provigil (modafinil) tablets |
- |
- |
x |
- |
- |
- |
- |
- |
Rebetol (ribavirin) capsules and oral solution |
- |
- |
x |
x |
- |
- |
- |
- |
Rythmol SR (propafenone hydrochloride) extended-release capsules |
- |
- |
x |
x |
x |
- |
- |
- |
Sprycel (dasatinib) tablets |
- |
- |
x |
x |
- |
- |
- |
- |
Combivir (lamivudine/zidovudine) tablets |
- |
- |
- |
x |
- |
- |
- |
- |
Cyanokit (hydroxocobalamin) intravenous use |
- |
- |
- |
x |
- |
- |
- |
- |
Eligard (leuprolide acetate) for injectable suspension |
- |
- |
- |
x |
- |
- |
- |
- |
Finacea (azelaic acid) gel |
- |
- |
- |
x |
- |
- |
- |
- |
Paxil (paroxetine HCl) tablets, oral solution and Paxil CR tablets |
- |
- |
- |
x |
x |
- |
- |
- |
Stalevo (levodopa/carbidopa/entacapone) tablets |
- |
- |
- |
x |
- |
- |
- |
- |
Cancidas (caspofungin acetate) for Injection |
- |
- |
- |
- |
x |
- |
- |
- |
Copegus (ribavirin) tablets |
- |
- |
- |
- |
x |
- |
- |
- |
Lupron Depot and Lupron Depot 3 month (leuprolide acetate) for depot suspension |
- |
- |
- |
- |
x |
- |
- |
- |
Proscar (finasteride) tablets |
- |
- |
- |
- |
x |
x |
- |
- |
Viread (tenofovir disoproxil fumarate) tablets |
- |
- |
- |
- |
x |
- |
- |
- |
Accolate (zafirlukast) tablets |
- |
- |
- |
- |
- |
x |
- |
- |
Pristiq (desvenlafaxine) extended-release tablets |
- |
- |
- |
- |
- |
- |
- |
- |
Note: the drug safety labeling changes listed above may not be a complete list. Please visit the link below for the entire current list and historical archive.
Other Drug News
Smarten Up About Antibiotics, CDC Urges
November 18, 2010 Knowing when to take antibiotics - and when not to - can help fight the rise of deadly "superbugs," say experts at the United States Centers for Disease Control and Prevention.
Severe Acne May Up Suicide Risk: Study
November 11, 2010 Severe acne may significantly increase suicide risk, and patients taking isotretinoin (Accutane) for the skin condition should be monitored for at least a year after treatment ends, Swedish researchers report.
Long-Term Statin Use Won't Raise Cancer Risk: Study
November 10, 2010 Long term use of cholesterol-lowering drugs called statins does not increase the risk of cancer and may even decrease users' risks for lymphoma, melanoma and endometrial tumors, a new study finds.
Few Young Women Getting Cervical Cancer Vaccine
November 9, 2010 Few teenage girls and young women are getting the human papillomavirus vaccine (HPV), and many of those who start the regimen fail to take all three doses, new research reveals.
Fish Oil Supplements May Not Slow Alzheimer's
November 2, 2010 One of the main components of fish oil doesn't help slow the development of symptoms in patients with early Alzheimer's, although experts aren't ruling out the possibility that supplementation given earlier might help prevent the disease. |
|
|
FDA MedWatch Alerts
Tools & Helpful Links
Medical EncyclopediaUse this feature to find information on diseases, symptoms, injuries, medical tests and surgical procedures.
Pill IdentifierThe Pill Identifier enables a search for unidentified pills by imprint code or shape/color.
Drug Interactions CheckerIncreasingly popular as more healthcare professionals and consumers make the effort to seek detailed information on drug-drug and drug-food interactions.
New DrugsAll the latest information on FDA Approvals and recent additions to the database.
News & ArticlesRoundup of recent drug-related news and press releases. also latest news from FDA Medwatch service including timely publication of recalls, withdrawals, warnings, and label/packaging changes.
About This Newsletter
Drugs.com is not affiliated with any pharmaceutical company. We are dedicated to providing consumers and health professionals with objective information about prescription-medication discoveries and side effects.
This information is not intended to be medical advice. You should contact your physician before making any changes to your health care. Drugs.com is not responsible for content provided by third-party web sites.
About Your Subscription
We sent this e-mail to %PERS_EMAIL% at your request.
Your Feedback
We always appreciate feedback so if you wish to give us your comments/ praise/ rebuke please Contact Us.
Thanks so much for your continued support!
The Editorial Team
Drugs.com
|